445 related articles for article (PubMed ID: 29488170)
1. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
[TBL] [Abstract][Full Text] [Related]
2. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting.
Md S; Kuldeep Singh JKA; Waqas M; Pandey M; Choudhury H; Habib H; Hussain F; Hussain Z
Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Efficient approach to maximize dermal targeting and anti-dermatitis efficacy.
Zhuo F; Abourehab MAS; Hussain Z
Carbohydr Polym; 2018 Oct; 197():478-489. PubMed ID: 30007638
[TBL] [Abstract][Full Text] [Related]
4. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
5. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
6. Effective topical delivery systems for corticosteroids: dermatological and histological evaluations.
Eroğlu İ; Azizoğlu E; Özyazıcı M; Nenni M; Gürer Orhan H; Özbal S; Tekmen I; Ertam İ; Ünal İ; Özer Ö
Drug Deliv; 2016 Jun; 23(5):1502-13. PubMed ID: 25259424
[TBL] [Abstract][Full Text] [Related]
7. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
8. Skin targeting by chitosan/hyaluronate hybrid nanoparticles for the management of irritant contact dermatitis: In vivo therapeutic efficiency in mouse-ear dermatitis model.
Abuelella KE; Abd-Allah H; Soliman SM; Abdel-Mottaleb MMA
Int J Biol Macromol; 2023 Mar; 232():123458. PubMed ID: 36709804
[TBL] [Abstract][Full Text] [Related]
9. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
10. Biophysical elucidation of the mechanism of enhanced drug release and topical delivery from polymeric film-forming systems.
Garvie-Cook H; Frederiksen K; Petersson K; Guy RH; Gordeev SN
J Control Release; 2015 Aug; 212():103-12. PubMed ID: 26087467
[TBL] [Abstract][Full Text] [Related]
11. Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin.
Frederiksen K; Guy RH; Petersson K
Eur J Pharm Biopharm; 2015 Apr; 91():9-15. PubMed ID: 25595740
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y
Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821
[TBL] [Abstract][Full Text] [Related]
13. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
Umerska A; Corrigan OI; Tajber L
Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles.
Zhang J; Smith E
J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362
[TBL] [Abstract][Full Text] [Related]
15. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.
Schlupp P; Blaschke T; Kramer KD; Höltje HD; Mehnert W; Schäfer-Korting M
Skin Pharmacol Physiol; 2011; 24(4):199-209. PubMed ID: 21346400
[TBL] [Abstract][Full Text] [Related]
16. New nanoparticles for topical ocular delivery of erythropoietin.
Silva B; Marto J; Braz BS; Delgado E; Almeida AJ; Gonçalves L
Int J Pharm; 2020 Feb; 576():119020. PubMed ID: 31935477
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development.
Nagaich U; Gulati N
Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874
[TBL] [Abstract][Full Text] [Related]
18. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.
Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA
Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells.
Nokhodi F; Nekoei M; Goodarzi MT
J Mater Sci Mater Med; 2022 Feb; 33(2):24. PubMed ID: 35157166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
